InvestorsObserver
×
News Home

Can Gilead Sciences, Inc. (GILD) Stock Rise to the Top of Healthcare Sector Tuesday?

Tuesday, September 21, 2021 02:16 PM | InvestorsObserver Analysts

Mentioned in this article

Can Gilead Sciences, Inc. (GILD) Stock Rise to the Top of Healthcare Sector Tuesday?

Gilead Sciences, Inc. (GILD) is near the top in its sector according to InvestorsObserver. GILD gets an overall rating of 61. That means it scores higher than 61% of stocks. Gilead Sciences, Inc. gets a 92 rank in the Healthcare sector. Healthcare is number 7 out of 11 sectors.

Overall Score - 61
GILD has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on GILD!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 61 means the stock is more attractive than 61 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Gilead Sciences, Inc. Stock Today?

Gilead Sciences, Inc. (GILD) stock is trading at $71.82 as of 2:01 PM on Tuesday, Sep 21, an increase of $0.86, or 1.21% from the previous closing price of $70.96. The stock has traded between $71.11 and $72.06 so far today. Volume today is low. So far 3,563,245 shares have traded compared to average volume of 6,558,548 shares. Click Here to get the full Stock Report for Gilead Sciences, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App